Aurora Cannabis Inc. vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
4.8
Bearish
Overall
6.3
Neutral
Quality
Health
Growth
Valuation
Sentiment
ACB
Clean balance sheet with low leverage (0.2× debt-to-equity).
⚠ currently unprofitable (-23% margin).
UNH
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
BUY
Target $6.42 (+84.5%)
1 analysts
BUY
Target $387.27 (+5.0%)
26 analysts
Fundamentals
ACB
UNH
—
Trailing P/E
27.9×
-31.6×
Forward P/E
17.8×
-22.5%
Profit Margin
2.7%
36.0%
Gross Margin
18.8%
-15.5%
ROE
12.2%
6.8%
Revenue Growth
2.0%
-94.7%
Earnings Growth
0.7%
1.32
Beta
0.41
—
Price / Book
—
$206M
Market Cap
$334.9B
$3 – $7
52-Week Range
$235 – $410
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →